April 20, 2006
Gates Grant Seeks Vaccine for Pneumonia
The Bill & Melinda Gates Foundation plans to spend $75-million over five years to develop a vaccine to prevent the spread of pneumonia.
The money will support efforts by Path, a nonprofit group in Seattle, to work with pharmaceutical and biotechnology companies to develop a vaccine that targets several strains of pneumococcus, the bacterium that triggers pneumonia.
The disease kills up to one million children a year, 90 percent of whom live in poor countries.
The
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
Get more great stories about the nonprofit world delivered to your inbox every weekday. 
